From CTV News:
A federal body that reviews medications has recommended that a high-cost drug for treating one form of the leading cause of vision loss among older Canadians be covered by provincial insurance plans.
The Common Drug Review recommended Friday that provincial drug plans cover the drug Lucentis for the "wet" form of age-related macular degeneration, but limit coverage to 15 vials "to treat the better-seeing eye."
The CDR said Lucentis has been shown to be effective in stabilizing and improving sight in people with wet macular degeneration. ...more
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment